Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 50

Biotechnology

WHO bestowed posthumous award on the late Henrietta Lacks
Biotechnology | COVID-19 | HIV | Life Science History | Non-Profit Research | Polio | Therapeutics | Vaccine | WHO

WHO bestowed posthumous award on the late Henrietta Lacks

On Oct. 13, 2021, the World Health Organization (WHO) honoured the late Henrietta Lacks with a WHO Director-General’s…

Read More WHO bestowed posthumous award on the late Henrietta LacksContinue

Lucira’s Health COVID-19 test approved for sale in Singapore
Biotechnology | COVID-19

Lucira’s Health COVID-19 test approved for sale in Singapore

On Oct. 12, 2021, Lucira Health announced that it had received PSAR approval for its Lucra CHECK IT…

Read More Lucira’s Health COVID-19 test approved for sale in SingaporeContinue

Moderna announced COVAX exercised option to purchase 176.5 million additional doses of Moderna’s COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced COVAX exercised option to purchase 176.5 million additional doses of Moderna’s COVID-19 vaccine

On Oct. 12, 2021, Moderna announced that Gavi, the Vaccine Alliance had exercised its option to purchase an…

Read More Moderna announced COVAX exercised option to purchase 176.5 million additional doses of Moderna’s COVID-19 vaccineContinue

INOVIO announced preprint publication of homologous boosting data for its COVID-19 DNA vaccine candidate  INO-4800
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO announced preprint publication of homologous boosting data for its COVID-19 DNA vaccine candidate INO-4800

On Oct. 12, 2021, Inovio Pharmaceuticals announced online preprint publication in MedRxiv of Phase 1 clinical data on…

Read More INOVIO announced preprint publication of homologous boosting data for its COVID-19 DNA vaccine candidate INO-4800Continue

Washington University School of Medicine reported antiviral compound blocked SARS-CoV-2 from entering cells
Biotechnology | COVID-19 | Therapeutics

Washington University School of Medicine reported antiviral compound blocked SARS-CoV-2 from entering cells

On Oct. 11, 2021, scientists at Washington University School of Medicine in St. Louis announced they had developed…

Read More Washington University School of Medicine reported antiviral compound blocked SARS-CoV-2 from entering cellsContinue

INOVIO expanded INNOVATE phase 3 for INO-4800 to include Colombia
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO expanded INNOVATE phase 3 for INO-4800 to include Colombia

On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…

Read More INOVIO expanded INNOVATE phase 3 for INO-4800 to include ColombiaContinue

PerkinElmer received FDA Emergency Use Authorization for respiratory SARS-CoV-2 panel
Biotechnology | COVID-19 | FDA | Infectious Disease | Influenza | Therapeutics

PerkinElmer received FDA Emergency Use Authorization for respiratory SARS-CoV-2 panel

On Oct. 7, 2021, PerkinElmer announced that the U.S. Food and Drug Administration (FDA) had issued Emergency Use…

Read More PerkinElmer received FDA Emergency Use Authorization for respiratory SARS-CoV-2 panelContinue

Duke University-led study showed Vaxart’s oral COVID-19 vaccine candidate reduced transmission of SARS-CoV-2 infection
Biotechnology | COVID-19 | Infectious Disease | Influenza | Vaccine

Duke University-led study showed Vaxart’s oral COVID-19 vaccine candidate reduced transmission of SARS-CoV-2 infection

On Oct. 7, 2021, Vaxart announced that a Duke University-led study published in bioRxiv showed that Vaxart’s (investigational…

Read More Duke University-led study showed Vaxart’s oral COVID-19 vaccine candidate reduced transmission of SARS-CoV-2 infectionContinue

Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per year
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per year

On Oct. 7, 2021, Moderna announced it was building a state-of-the-art mRNA facility in Africa with the goal…

Read More Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per yearContinue

Washington University School of Medicine in St. Louis led pediatric COVID-19 vaccine trial launched
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Washington University School of Medicine in St. Louis led pediatric COVID-19 vaccine trial launched

On Oct. 6, 2021, Washington University School of Medicine announced the start of a pediatric COVID-19 vaccine clinical…

Read More Washington University School of Medicine in St. Louis led pediatric COVID-19 vaccine trial launchedContinue

Moderna announced EMA authorized third dose of COVID-19 vaccine for immunocompromised individuals aged 12 years and older
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced EMA authorized third dose of COVID-19 vaccine for immunocompromised individuals aged 12 years and older

On Oct. 5, 2021, Moderna announced that the European Medicines Agency (EMA) had authorized a third dose of…

Read More Moderna announced EMA authorized third dose of COVID-19 vaccine for immunocompromised individuals aged 12 years and olderContinue

the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewal
Biotechnology | NIH | Oncology | Therapeutics

the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewal

On Oct. 4, 2021, the Fred & Pamela Buffett Cancer Center announced it had successfully renewed its National…

Read More the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewalContinue

Dynavax and U.S. Department of Defense announced collaboration to develop adjuvanted plague vaccine
Biotechnology | Infectious Disease | Plague | Vaccine

Dynavax and U.S. Department of Defense announced collaboration to develop adjuvanted plague vaccine

On Oct. 4, 2021, Dynavax Technologies and the U.S. Department of Defense (DOD) announced Dynavax had executed an…

Read More Dynavax and U.S. Department of Defense announced collaboration to develop adjuvanted plague vaccineContinue

Pfizer and BioNTech received CHMP positive opinion for COVID-19 vaccine booster in the European Union
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics | Vaccine

Pfizer and BioNTech received CHMP positive opinion for COVID-19 vaccine booster in the European Union

On Oct. 4, 2021, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…

Read More Pfizer and BioNTech received CHMP positive opinion for COVID-19 vaccine booster in the European UnionContinue

World’s oldest evidence for the earliest small-scale plant cultivation was discovered
Agriculture | Biotechnology | Life Science History | Prehistory

World’s oldest evidence for the earliest small-scale plant cultivation was discovered

World’s oldest evidence dating to 23000 BCE for the earliest small-scale plant cultivation was discovered by Dani Nadel…

Read More World’s oldest evidence for the earliest small-scale plant cultivation was discoveredContinue

Farmers in China, Egypt and Sumeria began using fermentation
Agriculture | Biotechnology | Life Science History | Prehistory

Farmers in China, Egypt and Sumeria began using fermentation

Around 8000 BCE, farmers in China, Egypt and Sumeria began using fermentation to produce cheese and wine. One…

Read More Farmers in China, Egypt and Sumeria began using fermentationContinue

Earliest known evidence of cheese making found in Croatia, Poland and Switzerland
Agriculture | Biotechnology | Life Science History

Earliest known evidence of cheese making found in Croatia, Poland and Switzerland

Earliest known evidence of cheese making was found in Croatia dated to 7200 BCE. Residues from sherds of…

Read More Earliest known evidence of cheese making found in Croatia, Poland and SwitzerlandContinue

Earliest physical trace of beer found at a site called Godin Tepe
Agriculture | Biotechnology | Life Science History

Earliest physical trace of beer found at a site called Godin Tepe

The earliest physical trace of beer dates back to the late fourth millennium BC in present day Iran…

Read More Earliest physical trace of beer found at a site called Godin TepeContinue

Chinese healers created the first antibiotic to treat boils
Biotechnology | Life Science History | Medicine | Prehistory

Chinese healers created the first antibiotic to treat boils

Around 600 BCE, Chinese healers created the first antibiotic – moldy soybean curds – to treat boils.

Read More Chinese healers created the first antibiotic to treat boilsContinue

Hippocrates described mumps, diphtheria, epidemic jaundice, and other conditions
Biotechnology | Disease | Life Science History | Prehistory

Hippocrates described mumps, diphtheria, epidemic jaundice, and other conditions

Around 500 BCE, Hippocrates, a pioneering physician in the history of Medicine, and considered as the principal author…

Read More Hippocrates described mumps, diphtheria, epidemic jaundice, and other conditionsContinue

Chinese growers used powdered chrysanthemum (pyrethrins) as the first insecticide
Agriculture | Biotechnology | Life Science History | Prehistory

Chinese growers used powdered chrysanthemum (pyrethrins) as the first insecticide

Around 100 BCE, Chinese growers used powdered chrysanthemum (pyrethrins) as the first insecticide.

Read More Chinese growers used powdered chrysanthemum (pyrethrins) as the first insecticideContinue

Merck and Ridgeback’s oral antiviral reduced risk of hospitalization or death for patients with COVID-19 in positive phase 3 study
Biotechnology | COVID-19 | FDA | Pharmaceutical | Therapeutics

Merck and Ridgeback’s oral antiviral reduced risk of hospitalization or death for patients with COVID-19 in positive phase 3 study

On Oct. 1, 2021, Merck and Ridgeback Biotherapeutics announced that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine,…

Read More Merck and Ridgeback’s oral antiviral reduced risk of hospitalization or death for patients with COVID-19 in positive phase 3 studyContinue

Labcorp received EUA for at home collection kit for combined COVID-19 and flu detection
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza

Labcorp received EUA for at home collection kit for combined COVID-19 and flu detection

On Oct. 1, 2021, LabCorp announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…

Read More Labcorp received EUA for at home collection kit for combined COVID-19 and flu detectionContinue

COVID-19 vaccinated vs. non-vaccinated
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medical Device | Neurology | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine

COVID-19 vaccinated vs. non-vaccinated

This cartoon illustrates the various issues facing individuals across the U.S. who are vaccinated against COVID-19 verus those…

Read More COVID-19 vaccinated vs. non-vaccinatedContinue

Pfizer reported positive top-line results of phase 3 study exploring coadministration of Prevnar 20 With seasonal Flu vaccine
Biotechnology | COVID-19 | FDA | Pharmaceutical | Therapeutics

Pfizer reported positive top-line results of phase 3 study exploring coadministration of Prevnar 20 With seasonal Flu vaccine

On Sept. 29, 2021, Pfizer and BioNTech announced they had submitted data to the U.S. Food and Drug…

Read More Pfizer reported positive top-line results of phase 3 study exploring coadministration of Prevnar 20 With seasonal Flu vaccineContinue

NEJM published positive phase 3 trial resulted for REGEN-COV (casirivimab and imdevimab) to treat COVID-19
Biotechnology | COVID-19 | Therapeutics

NEJM published positive phase 3 trial resulted for REGEN-COV (casirivimab and imdevimab) to treat COVID-19

On Sept. 29, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) published positive detailed results…

Read More NEJM published positive phase 3 trial resulted for REGEN-COV (casirivimab and imdevimab) to treat COVID-19Continue

Phase II/III trial showed Ronapreve (casirivimab and imdevimab) significantly reduced viral load in patients hospitalised with COVID-19
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

Phase II/III trial showed Ronapreve (casirivimab and imdevimab) significantly reduced viral load in patients hospitalised with COVID-19

On Sept. 29, 2021, Roche confirmed positive data from the phase II/III 2066 study, investigating Ronapreveル (casirivimab and…

Read More Phase II/III trial showed Ronapreve (casirivimab and imdevimab) significantly reduced viral load in patients hospitalised with COVID-19Continue

2022 Breakthrough Prize in Life Sciences awarded to Penn Medicine mRNA pioneers Drew Weissman and Katalin Karik
Biotechnology | COVID-19 | Therapeutics | Vaccine

2022 Breakthrough Prize in Life Sciences awarded to Penn Medicine mRNA pioneers Drew Weissman and Katalin Karik

On Sept. 29, 2021, the University of Pennsylvania announced that the Breakthrough Prize in Life Sciences was awarded…

Read More 2022 Breakthrough Prize in Life Sciences awarded to Penn Medicine mRNA pioneers Drew Weissman and Katalin KarikContinue

NIAID issued new awards to fund ‘pan-coronavirus’ vaccines
Biotechnology | Vaccine

NIAID issued new awards to fund ‘pan-coronavirus’ vaccines

On Sept. 28, 2021, the National Institute of Allergy and Infectious Diseases announced it had awarded approximately $36.3…

Read More NIAID issued new awards to fund ‘pan-coronavirus’ vaccinesContinue

Sanofi terminated mRNA COVID-19 vaccine development to focus on recombinant vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Pharmaceutical | Vaccine

Sanofi terminated mRNA COVID-19 vaccine development to focus on recombinant vaccine candidate

On Sept. 28, 2021, Sanofi announced that it had terminated plans for its own mRNA-based COVID-19 vaccine given…

Read More Sanofi terminated mRNA COVID-19 vaccine development to focus on recombinant vaccine candidateContinue

Page navigation

Previous PagePrevious 1 … 48 49 50 51 52 … 160 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search